HOME
ABOUT DNDi
ABOUT THIS SPECIAL ISSUE
EDITORIAL: "From Pipeline to the Patients: a Changing Landscape for VL"
CALENDAR
HOW CAN YOU HELP DNDi?
VL Strategy
Developping New Health Tools for VL Patients
In the Media
The Fever of the Poor
Clinical Projects
VL Combination Therapy in Asia
VL Cinical Studies in East Africa
Prospects of Engaging VL Clinical Research for Latin America
Clinical Projects
Seven-Year-Old Saisuru from Uganda: One Case among Many
Clinical Projects
LEAP: A Step Together in the Right Direction
Kala Azar
Visceral Leishmaniasis (VL)
Drug Discovery
Challenges to Finding Drug Candidates that can enter Clinical Development
Preclinical
Promising Results from the VL Lead Optimisation Consortium with Advinus
Fundraising
Balanced Funding Supports DNDi'S VL Portfolio
Access to Treatments
There can be no Health Benefit without Access to Treatments
PUBLICATIONS
Recent VL Scientific Publications
DNDi News
NECT, a New Combination Therapy against Sleeping Sickness Will Now be Available
Els, a Mover and Shaker, from Concept to Care!
NEW Addresses of Regional Offices in Rio, USA and Japan
WorldLeish4: DNDi Sponsors Two Symposia on the Path to Delivering Better Treatments for VL
News from Donors
Contact DNDi

Contact DNDi
For any further information, please contact our communication department:
Published by Drugs for Neglected Diseases Initiative - 15 Chemin Louis-Dunant 1202 Geneva Switzerland - Photo credits: DNDi unless otherwise stated - Editor: Sadia Kaenzig - Tel: +41 22 906 9230 - Fax: +41 22 906 9231 - www.dndi.org